(Q43056329)

13 November 2017

title

Neutropenia as a prognostic factor in advanced gastric cancer patients undergoing second-line chemotherapy with weekly paclitaxel (English)

1 reference

13 November 2017

1 reference

2

1 reference

13 November 2017

K Shitara

1

1 reference

13 November 2017

D Takahari

3

1 reference

13 November 2017

T Yokota

4

1 reference

13 November 2017

T Shibata

5

1 reference

13 November 2017

T Ura

6

1 reference

13 November 2017

S Ito

7

1 reference

13 November 2017

A Sawaki

8

1 reference

13 November 2017

M Tajika

9

1 reference

13 November 2017

H Kawai

10

1 reference

13 November 2017

K Muro

11

1 reference

13 November 2017

publication date

21 May 2010

1 reference

13 November 2017

1 reference

13 November 2017

volume

21

1 reference

13 November 2017

issue

12

1 reference

13 November 2017

page(s)

2403-2409

1 reference

How to calculate the dose of chemotherapy

13 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ248

Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ248

A randomised study comparing standard dose carboplatin with chlorambucil and carboplatin in advanced ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ248

Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ248

Chemotherapy-induced neutropenia as a prognostic factor in advanced non-small-cell lung cancer: results from Japan Multinational Trial Organization LC00-03.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ248

Predictive value of chemotherapy-induced neutropenia for the efficacy of oral fluoropyrimidine S-1 in advanced gastric carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ248

Neutropaenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ248

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ248

Weekly paclitaxel in the adjuvant treatment of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ248

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDQ248

1 reference

13 November 2017

1 reference